Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Esperion Therapeutics, Inc. | 186,989 | reported | 01 Jul 2013 | tx 8+222,850−252,533 |
| GILEAD SCIENCES, INC. | 100,000 | reported | 06 May 2009 | tx 6+234,831 |
| MAXYGEN INC | 60,000 | reported | 06 Jun 2012 | tx 9+166,888 |
| NewAmsterdam Pharma Co N.V. | 10,806 | reported | 11 Mar 2026 | tx 20+124,395−120,732 |
| CymaBay Therapeutics, Inc. | 9,000 | reported | 24 Jun 2015 | tx 11+81,606−3,721 |
| Audentes Therapeutics, Inc. | 0 | reported | 15 Jan 2020 | tx 87+77,833−689,766 |
| CV THERAPEUTICS INC | 0 | reported | 16 Apr 2009 | tx 128+2,288,585.663−2,017,628 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Mar 2026 | SALE | NewAmsterdam Pharma Co N.V. | 446 | 31.23 USD | |
| 11 Mar 2026 | SALE | NewAmsterdam Pharma Co N.V. | 44,173 | 30.41 USD | |
| 09 Mar 2026 | EXERCISE | NewAmsterdam Pharma Co N.V. | 44,619 | 11.50 USD | |
| 06 Mar 2026 | SALE | NewAmsterdam Pharma Co N.V. | 28,186 | 29.41 USD | |
| 09 Mar 2026 | EXERCISE | NewAmsterdam Pharma Co N.V. | 44,619 | 0.00 USD | deriv |
| 07 Jan 2026 | GRANT_AWARD | NewAmsterdam Pharma Co N.V. | 3,400 | — | |
| 07 Jan 2026 | GRANT_AWARD | NewAmsterdam Pharma Co N.V. | 15,300 | 0.00 USD | deriv |
| 01 Jun 2025 | EXERCISE | NewAmsterdam Pharma Co N.V. | 68 | 0.00 USD | |
| 01 Jun 2025 | EXERCISE | NewAmsterdam Pharma Co N.V. | 68 | — | deriv |
| 01 May 2025 | EXERCISE | NewAmsterdam Pharma Co N.V. | 69 | 0.00 USD | |
| 01 May 2025 | EXERCISE | NewAmsterdam Pharma Co N.V. | 69 | — | deriv |
| 14 Apr 2025 | EXERCISE | NewAmsterdam Pharma Co N.V. | 69 | 0.00 USD | |
| 14 Apr 2025 | EXERCISE | NewAmsterdam Pharma Co N.V. | 69 | — | deriv |
| 26 Mar 2025 | EXERCISE | NewAmsterdam Pharma Co N.V. | 3,102 | 0.00 USD | |
| 26 Mar 2025 | GRANT_AWARD | NewAmsterdam Pharma Co N.V. | 3,308 | — | deriv |
| 26 Mar 2025 | EXERCISE | NewAmsterdam Pharma Co N.V. | 3,102 | — | deriv |
| 07 Jan 2025 | GRANT_AWARD | NewAmsterdam Pharma Co N.V. | 6,960 | — | |
| 06 Jan 2025 | GRANT_AWARD | NewAmsterdam Pharma Co N.V. | 32,500 | 0.00 USD | deriv |
| 13 Feb 2024 | PURCHASE | NewAmsterdam Pharma Co N.V. | 5,000 | 19.00 USD | first after silence |
| 01 Jan 2024 | GRANT_AWARD | NewAmsterdam Pharma Co N.V. | 10,000 | 0.00 USD | deriv |
| 15 Jan 2020 | TENDER | Audentes Therapeutics, Inc. | 3,555 | 60.00 USD | |
| 15 Jan 2020 | TENDER | Audentes Therapeutics, Inc. | 265,799 | 60.00 USD | |
| 15 Jan 2020 | TENDER | Audentes Therapeutics, Inc. | 13,678 | 60.00 USD | |
| 15 Jan 2020 | TENDER | Audentes Therapeutics, Inc. | 32,343 | 60.00 USD | |
| 15 Jan 2020 | OTHER | Audentes Therapeutics, Inc. | 18,000 | — | deriv |
1 purchase reported after at least 12 months of silence — most recent on 13 Feb 2024.